DekaBank Deutsche Girozentrale decreased its position in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 0.1% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 4,414,595 shares of the company’s stock after selling 2,532 shares during the quarter. Procter & Gamble comprises approximately 1.3% of DekaBank Deutsche Girozentrale’s investment portfolio, making the stock its 9th largest position. DekaBank Deutsche Girozentrale owned approximately 0.19% of Procter & Gamble worth $737,935,000 at the end of the most recent reporting period.
Several other hedge funds have also recently added to or reduced their stakes in the company. Norges Bank bought a new stake in shares of Procter & Gamble in the 4th quarter valued at $3,956,117,000. TD Asset Management Inc increased its stake in shares of Procter & Gamble by 114.9% in the 1st quarter. TD Asset Management Inc now owns 3,568,671 shares of the company’s stock valued at $579,017,000 after acquiring an additional 1,907,716 shares in the last quarter. Swedbank AB bought a new stake in shares of Procter & Gamble in the 1st quarter valued at $233,788,000. Ilex Capital Partners UK LLP bought a new stake in shares of Procter & Gamble in the 1st quarter valued at $228,212,000. Finally, Capital Research Global Investors increased its stake in shares of Procter & Gamble by 24.4% in the 1st quarter. Capital Research Global Investors now owns 5,560,887 shares of the company’s stock valued at $902,254,000 after acquiring an additional 1,089,102 shares in the last quarter. Institutional investors own 65.77% of the company’s stock.
Insider Buying and Selling
In related news, insider Balaji Purushothaman sold 8,842 shares of the business’s stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $164.90, for a total value of $1,458,045.80. Following the transaction, the insider now directly owns 11,537 shares of the company’s stock, valued at approximately $1,902,451.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In related news, insider Balaji Purushothaman sold 8,842 shares of the business’s stock in a transaction dated Thursday, August 1st. The stock was sold at an average price of $164.90, for a total value of $1,458,045.80. Following the sale, the insider now directly owns 11,537 shares in the company, valued at approximately $1,902,451.30. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Ma. Fatima Francisco sold 96,000 shares of the business’s stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $170.00, for a total value of $16,320,000.00. Following the completion of the sale, the chief executive officer now owns 13,721 shares in the company, valued at $2,332,570. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 375,553 shares of company stock valued at $63,829,141. 0.17% of the stock is owned by insiders.
Wall Street Analysts Forecast Growth
Check Out Our Latest Stock Analysis on Procter & Gamble
Procter & Gamble Price Performance
PG opened at $173.53 on Friday. The firm’s fifty day moving average price is $169.20 and its two-hundred day moving average price is $165.07. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.73 and a quick ratio of 0.53. The company has a market capitalization of $409.56 billion, a price-to-earnings ratio of 28.35, a P/E/G ratio of 3.77 and a beta of 0.41. The Procter & Gamble Company has a 1 year low of $141.45 and a 1 year high of $177.94.
Procter & Gamble (NYSE:PG – Get Free Report) last issued its quarterly earnings results on Tuesday, July 30th. The company reported $1.40 earnings per share for the quarter, topping analysts’ consensus estimates of $1.37 by $0.03. The company had revenue of $20.53 billion for the quarter, compared to the consensus estimate of $20.69 billion. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. The firm’s quarterly revenue was down .1% on a year-over-year basis. During the same period in the previous year, the firm earned $1.37 EPS. As a group, analysts anticipate that The Procter & Gamble Company will post 6.97 earnings per share for the current fiscal year.
Procter & Gamble Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Friday, July 19th were issued a $1.0065 dividend. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.32%. The ex-dividend date of this dividend was Friday, July 19th. Procter & Gamble’s dividend payout ratio (DPR) is currently 65.85%.
About Procter & Gamble
The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.
Further Reading
- Five stocks we like better than Procter & Gamble
- What is a Death Cross in Stocks?
- 3 Leveraged ETFs to Multiply Returns
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- A Tale of Two Titans: Unveiling the Value in Baidu and JD.com
- What to Know About Investing in Penny Stocks
- Is the AI-Capable iPhone 16 the Start of a Sales Super-Cycle?
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.